Crystalytics has developed a two-step analysis using polarization microscopy and Raman spectroscopy for diagnostic research into crystal-related diseases and diseases that are the result of the exposure to toxic particles.
Crystalytics has a comprehensive and growing database for the analysis of pathological crystals and toxic microparticles.
Crystalytics actively seeks new clinical application possibilities for its technology.
Our mission is to deliver optimal diagnostics for patients with crystal-related diseases and diseases that are the result of the exposure to toxic microparticles worldwide. We want to contribute to a correct and timely diagnosis with optimal care in a growing group of patients. Our innovation is based on clinical expertise and solid scientific research. The societal contribution to people and the environment is leading.
Through the application of a polarization microscope with integrated Raman technology for the analysis of all sorts of body fluids and tissues. We want to become the new standard method for the identification of crystals and toxic microparticles. We offer a sustainable, affordable, and user-friendly technology that is suitable for use in any hospital or laboratory.
Our unique technology offers an innovative combination of polarization microscopy and Raman spectroscopy (iRPolM).
Polarization microscopy has been considered the gold standard in rheumatology since the 1960s, but it is subjective and lacks specificity. The addition of Raman spectroscopy precisely addresses this issue: it allows for the non-destructive acquisition of molecular fingerprints from the samples.
The Crystalytics device, the iRPolM, is easy to use due to its automated and integrated calibration procedures and simple measurement method. Our compact, tabletop device is highly suitable for point-of-care analyses in outpatient clinics and can be easily integrated into clinical laboratories. The interpretation of the results is automated through our database, requiring minimal additional training of the analyst.
The use of our device has been clinically proven effective for the diagnosis of gout (specificity 97.7%; 200 included patients [1]) and calcium pyrophosphate associated arthritis (specificity 99.1%; 400 included patients [2]). We are also able to diagnose hydroxyapatite-associated arthritis and other calcium containing crystals , which is not possible with the current polarization microscope [3].
In our pilot research in collaboration with Maastricht University Medical Center and Radboud University Medical Center, we have demonstrated that crystals (calcite) may also play a significant role in osteoarthritis [4].
Furthermore, our technology is suitable for detecting potentially pathogenic, toxic material. For instance, it can be applied to identify leaking silicone implants [5] and to identify microplastics and micrometals [6, 7].
Merumerkerkweg 1
6049 BX
Herten, The Netherlands
© 2024 Crystalytics BV
Crystalytics' website is currently under construction. Want to know more? We'd love to help! Send us a message and we'll get in touch soon.